- Home
- GNFT vs DHF Comparison
GNFT vs DHF Comparison
Compare GNFT & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- DHF
- Stock Information
- Founded
- GNFT 1999
- DHF 1998
- Country
- GNFT France
- DHF United States
- Employees
- GNFT N/A
- DHF N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- DHF Finance Companies
- Sector
- GNFT Health Care
- DHF Finance
- Exchange
- GNFT Nasdaq
- DHF Nasdaq
- Market Cap
- GNFT 179.7M
- DHF 188.4M
- IPO Year
- GNFT 2019
- DHF N/A
- Fundamental
- Price
- GNFT $3.74
- DHF $2.60
- Analyst Decision
- GNFT Strong Buy
- DHF
- Analyst Count
- GNFT 1
- DHF 0
- Target Price
- GNFT $13.00
- DHF N/A
- AVG Volume (30 Days)
- GNFT 9.9K
- DHF 451.1K
- Earning Date
- GNFT 09-19-2024
- DHF 01-01-0001
- Dividend Yield
- GNFT N/A
- DHF 7.65%
- EPS Growth
- GNFT N/A
- DHF N/A
- EPS
- GNFT 0.47
- DHF N/A
- Revenue
- GNFT $86,225,222.00
- DHF N/A
- Revenue This Year
- GNFT $145.20
- DHF N/A
- Revenue Next Year
- GNFT N/A
- DHF N/A
- P/E Ratio
- GNFT $7.89
- DHF N/A
- Revenue Growth
- GNFT 175.45
- DHF N/A
- 52 Week Low
- GNFT $3.35
- DHF $2.06
- 52 Week High
- GNFT $6.42
- DHF $2.39
- Technical
- Relative Strength Index (RSI)
- GNFT 49.41
- DHF 53.08
- Support Level
- GNFT $3.68
- DHF $2.53
- Resistance Level
- GNFT $4.03
- DHF $2.62
- Average True Range (ATR)
- GNFT 0.15
- DHF 0.03
- MACD
- GNFT 0.05
- DHF 0.00
- Stochastic Oscillator
- GNFT 57.35
- DHF 50.00
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. It invests predominantly in fixed-income securities of below-investment-grade credit quality.